Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Vistagen Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −2 vs. Q3 2025
- Shares held
- 13.8M
- −9.57M (−41.0%) vs. Q3 2025
- Total value
- $8.84M
- −$72.8M (−89.2%) vs. Q3 2025
- New holders
- 14
- 18 more added
- Sold out
- 16
- 15 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,060,000 | $2.03M | 0.04% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,676,580 | $1.77M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,824,738 | $1.21M | 0.00% | +137,003+8.1% | Added |
| ADAR1 Capital Management, LLC | 623,575 | $412.7K | 0.03% | +510,513+451.5% | Added |
| Jane Street Group, LLC | 527,127 | $348.9K | 0.00% | +224,444+74.2% | Added |
| Ikarian Capital, LLC | 519,077 | $343.6K | 0.04% | −101,792−16.4% | Reduced |
| BlackRock, Inc. | 422,759 | $279.8K | 0.00% | −369−0.1% | Reduced |
| Geode Capital Management, LLC | 352,836 | $233.6K | 0.00% | +54,556+18.3% | Added |
| Luminus Management LLC | 350,000 | $231.7K | 0.21% | +350,000 | New |
| Susquehanna International Group, LLP | 334,786 | $221.6K | 0.00% | +249,192+291.1% | Added |
| AdvisorShares Investments LLC | 250,188 | $165.6K | 0.03% | +43,190+20.9% | Added |
| StemPoint Capital LP | 616,749 | $142.1K | 0.02% | −1,871,936−75.2% | Reduced |
| Millennium Management LLC | 197,045 | $130.4K | 0.00% | +176,369+853.0% | Added |
| Two Sigma Investments, LP | 195,570 | $129.4K | 0.00% | −93,839−32.4% | Reduced |
| Renaissance Technologies LLC | 160,791 | $106.4K | 0.00% | −261,221−61.9% | Reduced |
| Dimensional Fund Advisors LP | 151,874 | $100.6K | 0.00% | +83,857+123.3% | Added |
| Two Sigma Advisers, LP | 137,732 | $91.2K | 0.00% | −19,300−12.3% | Reduced |
| Boothbay Fund Management, LLC | 134,571 | $89.1K | 0.00% | −62,453−31.7% | Reduced |
| State Street Corp | 121,114 | $80.2K | 0.00% | +24,256+25.0% | Added |
| Group One Trading, L.P. | 106,137 | $70.3K | 0.00% | +77,209+266.9% | Added |
| Omers Administration Corp | 103,400 | $68.4K | 0.00% | +103,400 | New |
| Diadema Partners LP | 100,000 | $66.2K | 0.04% | −249,789−71.4% | Reduced |
| Tudor Investment Corp Et Al | 76,172 | $50.4K | 0.00% | +76,172 | New |
| Northern Trust Corp | 72,655 | $48.1K | 0.00% | +24,562+51.1% | Added |
| Seven Fleet Capital Management LP | 62,701 | $41.5K | 0.03% | +62,701 | New |
| Qube Research & Technologies Ltd | 60,139 | $39.8K | 0.00% | +60,139 | New |
| Occudo Quantitative Strategies LP | 59,038 | $39.1K | 0.00% | +16,334+38.2% | Added |
| UBS Group AG | 51,993 | $34.4K | 0.00% | +26,326+102.6% | Added |
| American Century Companies Inc | 48,770 | $32.3K | 0.00% | +7,698+18.7% | Added |
| Virtu Financial LLC | 37,739 | $25.0K | 0.00% | +37,739 | New |
| HRT Financial LP | 37,585 | $24.0K | 0.00% | +37,585 | New |
| Engineers Gate Manager LP | 30,490 | $20.2K | 0.00% | +30,490 | New |
| Persistent Asset Partners Ltd | 26,612 | $17.6K | 0.01% | −48,707−64.7% | Reduced |
| Kestra Advisory Services, LLC | 26,033 | $17.2K | 0.00% | +6,000+30.0% | Added |
| Charles Schwab Investment Management Inc | 23,302 | $15.4K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 21,736 | $14.4K | 0.00% | +10,853+99.7% | Added |
| HighTower Advisors, LLC | 20,628 | $13.7K | 0.00% | −200−1.0% | Reduced |
| Lighthouse Investment Partners, LLC | 20,580 | $13.6K | 0.00% | +20,580 | New |
| Marshall Wace, LLP | 19,973 | $13.2K | 0.00% | +19,973 | New |
| Truvestments Capital LLC | 16,992 | $11.2K | 0.00% | +8,337+96.3% | Added |
| Caption Management, LLC | 16,770 | $11.1K | 0.00% | +16,770 | New |
| StoneX Group Inc. | 13,349 | $8.84K | 0.00% | +13,349 | New |
| Morgan Stanley | 12,658 | $8.38K | 0.00% | −14,876−54.0% | Reduced |
| DRW Securities, LLC | 10,000 | $6.62K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 8,564 | $5.67K | 0.00% | +8,564 | New |
| Advisor Group Holdings, Inc. | 5,269 | $3.48K | 0.00% | +1,176+28.7% | Added |
| Bank of America Corp | 3,145 | $2.08K | 0.00% | −31,512−90.9% | Reduced |
| Performa Ltd (US), LLC | 1,000 | $662 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 526 | $349 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 288 | $191 | 0.00% | −2−0.7% | Reduced |
| Jones Financial Companies LLLP | 114 | $75 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $19 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $11 | 0.00% | −271,809−100.0% | Reduced |
| BNP Paribas Arbitrage, SA | 13 | $9 | 0.00% | −43−76.8% | Reduced |
| CWM, LLC | 582 | $0 | 0.00% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −4,165,767−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −1,978,492−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −1,575,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Almitas Capital LLC | 0 | $0 | 0.00% | −261,399−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −122,062−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −69,712−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −67,770−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −60,152−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −31,486−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −15,752−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −12,573−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,453−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |